F001 The New Skin Frontier: Innovation at the Intersection of Industry and Academia
DESCRIPTION
Are you an innovator? Visionary? Problem solver? Entrepreneur? If you have a solution that could change the practice of dermatology, or medicine in general, we would love to hear about it! In this session, we welcome game changers from academia, industry, private practice, the tech field- anyone who can envision a better way forward.
This year, the "Future of Dermatology Symposium" will focus on the dynamic intersection of biopharma and academia. This session will feature expert lectures and abstract presentations on the latest advancements in dermatological research and technology. Attendees will explore the potential of new therapies, discuss emerging trends, and gain insights into how collaboration between industry and academia is paving the way for the next generation of dermatological treatments.
Our panel of experts in therapeutics, cosmetics, molecular technologies, AI, telemedicine, and mobile and imaging technologies will review applications and select the most ground-breaking abstracts and products for oral presentation at the Future of Dermatology Session.
This session is not certified for AMA PRA Category 1 CME Credit.
LEARNING OBJECTIVES
Explore Cutting-Edge Innovations: To highlight the latest advancements in dermatology, focusing on novel therapies and technologies emerging at the intersection of biopharma and academic research.
Foster Collaborative Dialogues: To facilitate discussions between biopharma professionals, academic researchers, and clinicians, encouraging collaboration to accelerate the development of groundbreaking dermatological treatments.
Showcase Promising Research and Clinical Applications: To present innovative research through abstract presentations that demonstrate how new findings are translating into practical solutions for dermatological care and patient outcomes.
SCHEDULE
6:00 PM
Introduction
Hensin Tsao, MD, PhD, FAAD
6:05 PM
The academic/industry interface
Eugene A. Bauer, MD, FAAD
6:25 PM
Science, Serendipity, and Strategy: Chance Favors the Prepared Mind
Richard Rox Anderson, MD, FAAD
7:00 PM
Panel discussion
Richard Rox Anderson, MD, FAAD, Eugene A. Bauer, MD, FAAD
7:20 PM
Magic Wand
Lilit Garibyan, PhD, MD, FAAD
7:40 PM
My Journey to Sibel
Steve Xu, MD
8:00 PM
Pi Health
Bobby Y. Reddy, MD, FAAD
8:20 PM
Town Hall and panel discussion
8:45 PM
Prolactin Receptor Antagonist ABS-201: An AI-Designed Therapy Demonstrating Superior Efficacy for Androgenetic Alopecia in Preclinical Studies
Amer-Denis Akkad
9:00 PM
A Novel More Effective Topical Therapeutic Approach for Treatment of Androgenic Alopecia: First in Human Trial Results for Topical ET-02
Jon Edelson
9:15 PM
AI-Driven Quantitative Analysis of Melanocytes and Melanin for Differential Diagnosis of Melanoma and Nevi Using FF-OCT
9:30 PM
Diagnostic Accuracy of Multi-Modal AI Models in Dermatological Diagnosis Using Smartphone-Style Images: A Study Using the Novel SCIN Dataset
Kevin Tabatabaei
9:45 PM
Rapid Margin Assessment Using High-Frequency Bioelectrical Impedance Spectroscopy During Mohs Micrographic Surgery
Donato Ceres
SPEAKERS
Amer-Denis Akkad
Absci
Richard Rox Anderson, MD, FAAD
Eugene A. Bauer, MD, FAAD
Evommune, Inc., Founder, Member of the Board of Directors and Chief Medical Officer
Donato Ceres
Novascan
Jon Edelson
Eirion Therapeutics, Inc.
Lilit Garibyan, PhD, MD, FAAD
Harvard Medical School & Wellman Center/Mass General Hospital
Kenneth B. Gordon, MD, FAAD
Joseph C. Kvedar, MD, FAAD
Massachusetts General Hospital
Luísa Polo Silveira, MD
Bobby Y. Reddy, MD, FAAD
Kevin Tabatabaei
Mayo Clinic Alix School of Medicine
Hensin Tsao, MD, PhD, FAAD
Sandy Sharon Tsao, MD, FAAD
Steve Xu, MD
Sibel Health
SPEAKER DISCLOSURES
Amer-Denis Akkad
No financial relationships exist with ineligible companies.
Richard Rox Anderson, MD, FAAD
Accure Acne Inc. – Advisory Board(Stock); AVAVA, LLC – Advisory Board(Stock); Blossom Innovations, LLC – Founder(Stock); Brixton Biosciences – Founder(Stock); Cytrellis Biosystems, Inc – Advisory Board(Stock); Massachusetts General Hospital – Employee(Patent royalties or other compensation for Intellectual Property Rights); Sofregen Medical, Inc. – Consultant(Stock Options);
Eugene A. Bauer, MD, FAAD
Biolojic Design – Board of Directors(Fees), Board of Directors(Stock); Evommune, Inc. – Board of Directors(Stock), Employee (w-2 relationship)(Salary), Founder(Stock); Rheos Medical – Board of Directors(Stock);
Donato Ceres
Novascan – Employee (w-2 relationship)(Salary);
Jon Edelson
Eirion Therapeutics – Employee (w-2 relationship)(Stock);
Lilit Garibyan, PhD, MD, FAAD
Annecy Bio – Board of Directors(Stock); Brixton Biosciences – Consultant(Fees), Stockholder(Stock); Clarity Cosmetics, Inc. – Stockholder Private Company(No Compensation Received); EyeCool – Stockholder(Stock); Matilda Venture Studio – Board of Directors(Stock);
Kenneth B. Gordon, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria); Othro Dermatologics – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Protagonist Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);
Joseph C. Kvedar, MD, FAAD
b.well – Stockholder(Stock Options); Corti – Advisory Board(Fees); Hoffman-La Roche Ltd. – Advisory Board(Fees); MD Revolution – Advisory Board(Stock Options); Medrock Ventures – Advisory Board(Fees); Piction Health – Advisory Board(Stock Options); Sweetch – Advisory Board(Honoraria);
Luísa Polo Silveira, MD
No financial relationships exist with ineligible companies.
Bobby Y. Reddy, MD, FAAD
Pi Health – Employee (w-2 relationship)(Salary);
Kevin Tabatabaei
No financial relationships exist with ineligible companies.
Hensin Tsao, MD, PhD, FAAD
Epiphany Dermatology – Advisory Board(Honoraria), Advisory Board(Stock Options); Massachusetts General Hospital – Employee(Salary); UpToDate, Inc. – Other(Honoraria); Worldcare Clinical, LLC – Consultant (1099 relationship)(Fees);
Sandy Sharon Tsao, MD, FAAD
Beiersdorf, Inc. – Consultant (1099 relationship)(Honoraria); Epiphany Dermatology – Advisory Board(Stock); WorldCare Clinical LLC – Consultant (1099 relationship)(Honoraria);
Steve Xu, MD
Maruho Co., Ltd – Investigator(Grants/Research Funding); Sibel Health Inc. – Founder(Stock);